ImmunityBio, Inc. earnings per share and revenue

IBRX earnings per share for the last quarter are -0.18 USD whereas the estimation was -0.20 USD which accounts for 7.69% surprise. Företagets omsättning för samma period uppgår till 12.50 k USD trots den uppskattade siffran 62.50 k USD. Estimated earnings per share for the next quarter are -0.16 USD, and revenue is expected to reach 14.71 M USD. Also watch annual changes over time to get a bigger picture of IBRX earnings per share and revenue dynamics.